F-3 EX-FILING FEES 0001723980 N/A N/A 0001723980 1 2026-07-02 2026-07-02 0001723980 2026-07-02 2026-07-02 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-3

China SXT Pharmaceuticals, Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Class A Ordinary Shares, no par value per share   (1)   Other   157,500,000   $ 2.4091   $ 379,433,250.00   0.0001381   $ 52,399.73
                                           
Total Offering Amounts:   $ 379,433,250.00         52,399.73
Total Fees Previously Paid:                
Total Fee Offsets:               0.00
Net Fee Due:             $ 52,399.73

__________________________________________
Offering Note(s)

(1) Consists of 157,500,000 Class A Shares held by the selling shareholder for resale. This registration statement also includes an indeterminate number of securities that may become offered, issuable or sold to prevent dilution resulting from stock splits, stock dividends and similar transactions, which are included pursuant to Rule 416 under the Securities Act of 1933, as amended.

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) promulgated under the Securities Act of 1933, as amended, based upon the average of the high ($2.9282) and low ($1.8901) prices of the Class A Ordinary Shares as reported on the Nasdaq Capital Market on June 29, 2026, which is a date within five (5) business days prior to the filing date of this registration statement.